Evaluation of Automated Molecular Testing Rollout for Tuberculosis Diagnosis Using Routinely Collected Surveillance Data — Uganda, 2012–2015

Scott, Colleen; Walusimbi, Simon; Kirenga, Bruce; Joloba, Moses; Winters, Muttamba; Abdunoor, Nyombi; Bain, Rommel; Alexander, Heather; Shinnick, Tom; Toney, Sean; Odeke, Rosemary; Mwangi, Christine; Birabwa, Estella; Dejene, Seyoum; Mugabe, Frank; YaDiul, Mukadi; Cavanaugh, J. Sean

doi:10.15585/mmwr.mm6612a6

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Evaluation of Automated Molecular Testing Rollout for Tuberculosis Diagnosis Using Routinely Collected Surveillance Data — Uganda, 2012–2015

Published Date:

Mar 31 2017

Publisher's site:

http://dx.doi.org/10.15585/mmwr.mm6612a6 New Site Icon

Source:

MMWR Morb Mortal Wkly Rep. 66(12):339-342.

[PDF-239.31 KB]

Details:

Alternative Title:

MMWR Morb Mortal Wkly Rep

Personal Author:

Scott, Colleen ; Walusimbi, Simon ; Kirenga, Bruce ; Joloba, Moses ; Winters, Muttamba ; ... More ▼

Description:

In 2012, Uganda introduced the use of GeneXpert MTB/RIF (Cepheid, Sunnyvale CA), a sensitive, automated, real-time polymerase chain reaction-based platform for tuberculosis (TB) diagnosis, for programmatic use among children, adults with presumptive human immunodeficiency virus (HIV)-associated TB, and symptomatic persons at risk for rifampicin (RIF)-resistant TB. The effect of using the platform's Xpert MTB/RIF assay on TB care and control was assessed using routinely collected programmatic data; in addition, a retrospective review of district quarterly summaries using abstracted TB register data from purposively selected facilities in the capital city of Kampala was conducted. Case notification rates were calculated and nonparametric statistical methods were used for analysis. No statistically significant differences were observed in case notification rates before and after the Xpert MTB/RIF assay became available, although four of 10 districts demonstrated a statistically significant difference in bacteriologically confirmed TB. Once the GeneXpert MTB/RIF platform is established and refined, a more comprehensive evaluation should be conducted.

Subject:

[+]

Pubmed ID:

28358797

Pubmed Central ID:

PMC5657957

Document Type:

Journal Article

Place as Subject:

Uganda

Collection(s):

Morbidity and Mortality Weekly Report (MMWR)

Main Document Checksum:

[+]

Supporting Files:

mm6612a6.nxml

text/xml

No Related Documents.

You May Also Like:

Rollout of Xpert(®) MTB/RIF in Northwest Cambodia for the diagnosis of tuberculosis among PLHA

Personal Author:

Auld, S. C.; Moore, B. K.; Killam, W. P.; Eng, B.; Nong, K.; Pevzner, E. C.; Eam, K. K.; Eang, M. T.; Warren, D.; Whitehead, S. J.;

Corporate Authors:

Center for Global Health (U.S.)

Published Date:

21 December 2014

Source:

Public Health Action. 2014 Dec 21;4(4):216-21

Series:

PEPFAR

Description:

OBJECTIVE: To describe the implementation and utilization of the Xpert (®) MTB/RIF (Xpert) assay to diagnose tuberculosis (TB) among people living with the human immunodeficiency virus/acquired immune-deficiency syndrome (HIV/AIDS, PLHA) in Cambodia...

File Type:

[PDF - 164.74 KB]
MMWR. Morbidity and mortality weekly report, Vol. 66, no. 12, March 31, 2017

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Published Date:

March 31, 2017

Series:

MMWR. Morbidity and mortality weekly report ; v. 66, no. 12

File Type:

[PDF - 1.17 MB]
The effect of sputum quality and volume on the yield of bacteriologically-confirmed TB by Xpert MTB/RIF and smear

Personal Author:

Zimba, Onani; Tamuhla, Tsaone; Basotli, Joyce; Letsibogo, Gaoraelwe; Pals, Sherri; Mathebula, Unami; Mathoma, Anikie; Serumola, Christopher; Ramogale, Kitso; Boyd, Rosanna; Tran, Tiffany; Finlay, Alyssa; Auld, Andrew; Date, Anand; Alexander, Heather; Chihota, Violet; Agizew, Tefera;

Published Date:

June 13 2019

Source:

Pan Afr Med J. 2019; 33

Description:

IntroductionThe World Health Organization endorsed (2010) the use of Xpert MTB/RIF and countries are shifting from smear microscopy (smear)-based to Xpert MTB/RIF-based tuberculosis (TB) diagnostic algorithms. As with smear, sputum quality may predic...

File Type:

[PDF - 793.13 KB]
CDC Global AIDS Program International Laboratory Branch : building sustainable integrated laboratory capacity in PEPFAR countries

Corporate Authors:

Centers for Disease Control and Prevention (U.S.). Global AIDS Program. International Laboratory Branch.. United States. President's Emergency Plan for AIDS Relief..

Published Date:

2/4/10

Description:

The Global AIDS Program (GAP), through the President’s Emergency Plan for AIDS Relief (PEPFAR), supports over 70 countries, bringing to bear the technical expertise gained from CDC’s more than 60 year history as the premier U.S. agency for diseas...

File Type:

[PDF - 18.25 MB]
President’s Malaria Initiative : ninth annual report to Congress

Corporate Authors:

President's Malaria Initiative (U.S.). United States, Agency for International Development.. Centers for Disease Control and Prevention (U.S.).

Published Date:

April 2015

Description:

The fight against malaria is making historic gains across sub-Saharan Africa. In countries where insecticide-treated mosquito nets (ITNs), indoor residual spraying (IRS), improved diagnostic tests, and highly effective antimalarial drugs have been sc...

File Type:

[PDF - 6.19 MB]